Expression and purification of catalytically active human PHD3 in Escherichia coli

Protein Expression and Purification

Volumn 54, Issue 1, 2007, Pages 1-10

  Fedulova, Natalia ^a   Hanrieder, Jörg ^a   Bergquist, Jonas ^a   Emrén, Lars O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Chaperonine; Dioxygenase; EGLN; Hydroxyproline; Ischemia; Proline

Indexed keywords

CHAPERONIN; DEFEROXAMINE; DIOXYGENASE; EGLN3 PROTEIN, HUMAN; ESCHERICHIA COLI PROTEIN; GROE PROTEIN, E COLI; HEAT SHOCK PROTEIN; HYBRID PROTEIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMIDAZOLE; IMIDAZOLE DERIVATIVE; ISOPROPYL THIOGALACTOSIDE; NICKEL; UNCLASSIFIED DRUG; ZINC;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ARTICLE; BIOSYNTHESIS; CATALYSIS; CHEMISTRY; DRUG EFFECT; ESCHERICHIA COLI; GEL CHROMATOGRAPHY; GENETICS; HUMAN; HYDROXYLATION; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; TEMPERATURE;

AMINO ACID SEQUENCE; CATALYSIS; CHAPERONINS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, GEL; DEFEROXAMINE; DIOXYGENASES; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; HYDROXYLATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMIDAZOLES; ISOPROPYL THIOGALACTOSIDE; MASS SPECTROMETRY; NICKEL; RECOMBINANT FUSION PROTEINS; TEMPERATURE; ZINC;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

EID: 34247347412     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2007.02.018     Document Type: Article

References (52)

1. 2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol. 15 (1999) 551-578
2. Epstein A.C., Gleadle J.M., McNeill L.A., Hewitson K.S., O'Rourke J., Mole D.R., Mukherji M., Metzen E., Wilson M.I., Dhanda A., Tian Y.M., Masson N., Hamilton D.L., Jaakkola P., Barstead R., Hodgkin J., Maxwell P.H., Pugh C.W., Schofield C.J., and Ratcliffe P.J. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 107 (2001) 43-54
3. Bruick R.K., and McKnight S.L. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 294 (2001) 1337-1340
4. 2 sensing. Science 292 (2001) 464-468
5. 2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
6. 2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 7987-7992
7. Cockman M.E., Masson N., Mole D.R., Jaakkola P., Chang G.W., Clifford S.C., Maher E.R., Pugh C.W., Ratcliffe P.J., and Maxwell P.H. Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275 (2000) 25733-25741
8. Salceda S., and Caro J. Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J. Biol. Chem. 272 (1997) 22642-22647
9. Kallio P.J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H., and Poellinger L. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J. 17 (1998) 6573-6586
10. Metzen E., Berchner-Pfannschmidt U., Stengel P., Marxsen J.H., Stolze I., Klinger M., Huang W.Q., Wotzlaw C., Hellwig-Burgel T., Jelkmann W., Acker H., and Fandrey J. Intracellular localisation of human HIF-1α hydroxylases: implications for oxygen sensing. J. Cell Sci. 116 (2003) 1319-1326
11. Huang J., Zhao Q., Mooney S.M., and Lee F.S. Sequence determinants in hypoxia-inducible factor-1α for hydroxylation by the prolyl hydroxylases PHD1, PHD2, and PHD3. J. Biol. Chem. 277 (2002) 39792-39800
12. Hirsila M., Koivunen P., Gunzler V., Kivirikko K.I., and Myllyharju J. Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor. J. Biol. Chem. 278 (2003) 30772-30780
13. Ivan M., Haberberger T., Gervasi D.C., Michelson K.S., Gunzler V., Kondo K., Yang H., Sorokina I., Conaway R.C., Conaway J.W., and Kaelin Jr. W.G. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc. Natl. Acad. Sci. USA 99 (2002) 13459-13464
14. Wang G.L., and Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82 (1993) 3610-3615
15. Paul S.A., Simons J.W., and Mabjeesh N.J. HIF at the crossroads between ischemia and carcinogenesis. J. Cell Physiol. 200 (2004) 20-30
16. Ratan R.R., Siddiq A., Aminova L., Lange P.S., Langley B., Ayoub I., Gensert J., and Chavez J. Translation of ischemic preconditioning to the patient: prolyl hydroxylase inhibition and hypoxia inducible factor-1 as novel targets for stroke therapy. Stroke 35 (2004) 2687-2689
17. Oehme F., Jonghaus W., Narouz-Ott L., Huetter J., and Flamme I. A nonradioactive 96-well plate assay for the detection of hypoxia-inducible factor prolyl hydroxylase activity. Anal. Biochem. 330 (2004) 74-80
18. Masson N., Appelhoff R.J., Tuckerman J.R., Tian Y.M., Demol H., Puype M., Vandekerckhove J., Ratcliffe P.J., and Pugh C.W. The HIF prolyl hydroxylase PHD3 is a potential substrate of the TRiC chaperonin. FEBS Lett. 570 (2004) 166-170
19. Cobb R.R., McClary J., Manzana W., Finster S., Larsen B., Blasko E., Pearson J., Biancalana S., Kauser K., Bringmann P., Light D.R., and Schirm S. Cloning and characterization of the rat HIF-1α prolyl-4-hydroxylase-1 gene. Protein Expr. Purif. 42 (2005) 295-304
20. Hirsila M., Koivunen P., Xu L., Seeley T., Kivirikko K.I., and Myllyharju J. Effect of desferrioxamine and metals on the hydroxylases in the oxygen sensing pathway. FASEB J. 19 (2005) 1308-1310
21. McDonough M.A., Li V., Flashman E., Chowdhury R., Mohr C., Lienard B.M., Zondlo J., Oldham N.J., Clifton I.J., Lewis J., McNeill L.A., Kurzeja R.J., Hewitson K.S., Yang E., Jordan S., Syed R.S., and Schofield C.J. Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2). Proc. Natl. Acad. Sci. USA 103 (2006) 9814-9819
22. Björnestedt R., Widersten M., Board P.G., and Mannervik B. Design of two chimaeric human-rat class α glutathione transferases for probing the contribution of C-terminal segments of protein structure to the catalytic properties. Biochem. J. 282 Pt. 2 (1992) 505-510
23. Dale G.E., Schonfeld H.J., Langen H., and Stieger M. Increased solubility of trimethoprim-resistant type S1 DHFR from Staphylococcus aureus in Escherichia coli cells overproducing the chaperonins GroEL and GroES. Protein Eng. 7 (1994) 925-931
24. Kivirikko K.I., and Myllyla R. Posttranslational enzymes in the biosynthesis of collagen: intracellular enzymes. Methods Enzymol. 82 Pt. A (1982) 245-304
25. Layne E. Spectrophotometric and turbidimetric methods for measuring proteins. Methods Enzymol. 3 (1957) 447-454
26. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
27. Burnette W.N. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate - polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal. Biochem. 112 (1981) 195-203
28. Bessette P.H., Aslund F., Beckwith J., and Georgiou G. Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc. Natl. Acad. Sci. USA 96 (1999) 13703-13708
29. Warshakoon N.C., Wu S., Boyer A., Kawamoto R., Sheville J., Bhatt R.T., Renock S., Xu K., Pokross M., Zhou S., Walter R., Mekel M., Evdokimov A.G., and East S. Design and synthesis of substituted pyridine derivatives as HIF-1α prolyl hydroxylase inhibitors. Bioorg. Med. Chem. Lett. 16 (2006) 5616-5620
30. Taylor M.S. Characterization and comparative analysis of the EGLN gene family. Gene 275 (2001) 125-132
31. Nakayama K., Gazdoiu S., Abraham R., Pan Z.Q., and Ronai Z. Hypoxia-induced assembly of prolyl-hydroxylase, PHD3 into complexes: implications for its activity and susceptibility for degradation by the E3 ligase Siah2. Biochem. J. 401 (2007) 217-226
32. Cho H., Park H., and Yang E.G. A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases. Biochem. Biophys. Res. Commun. 337 (2005) 275-280
33. McNeill L.A., Flashman E., Buck M.R., Hewitson K.S., Clifton I.J., Jeschke G., Claridge T.D., Ehrismann D., Oldham N.J., and Schofield C.J. Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate. Mol. Biosyst. 1 (2005) 321-324
34. Georgiou G., and Valax P. Expression of correctly folded proteins in Escherichia coli. Curr. Opin. Biotechnol. 7 (1996) 190-197
35. Widersten M. Heterologous expression in Escherichia coli of soluble active-site random mutants of haloalkane dehalogenase from Xanthobacter autotrophicus GJ10 by coexpression of molecular chaperonins GroEL/ES. Protein Expr. Purif. 13 (1998) 389-395
36. Houry W.A., Frishman D., Eckerskorn C., Lottspeich F., and Hartl F.U. Identification of in vivo substrates of the chaperonin GroEL. Nature 402 (1999) 147-154
37. Frydman J., Nimmesgern E., Erdjument-Bromage H., Wall J.S., Tempst P., and Hartl F.U. Function in protein folding of TRiC, a cytosolic ring complex containing TCP-1 and structurally related subunits. EMBO J. 11 (1992) 4767-4778
38. Gao Y., Thomas J.O., Chow R.L., Lee G.H., and Cowan N.J. A cytoplasmic chaperonin that catalyzes beta-actin folding. Cell 69 (1992) 1043-1050
39. Lewis V.A., Hynes G.M., Zheng D., Saibil H., and Willison K. T-complex polypeptide-1 is a subunit of a heteromeric particle in the eukaryotic cytosol. Nature 358 (1992) 249-252
40. Wisén S., Jiang F., Bergman B., and Mannervik B. Expression and purification of the transcription factor NtcA from the cyanobacterium Anabaena PCC 7120. Protein Expr. Purif. 17 (1999) 351-357
41. Philip M., Jamaluddin M., Sastry R.V., and Chandra H.S. Nucleosome core histone complex isolated gently and rapidly in 2 M NaCl is octameric. Proc. Natl. Acad. Sci. USA 76 (1979) 5178-5182
42. Tuckerman J.R., Zhao Y., Hewitson K.S., Tian Y.M., Pugh C.W., Ratcliffe P.J., and Mole D.R. Determination and comparison of specific activity of the HIF-prolyl hydroxylases. FEBS Lett. 576 (2004) 145-150
43. McNeill L.A., Hewitson K.S., Gleadle J.M., Horsfall L.E., Oldham N.J., Maxwell P.H., Pugh C.W., Ratcliffe P.J., and Schofield C.J. The use of dioxygen by HIF prolyl hydroxylase (PHD1). Bioorg. Med. Chem. Lett. 12 (2002) 1547-1550
44. Landazuri M.O., Vara-Vega A., Viton M., Cuevas Y., and del Peso L. Analysis of HIF-prolyl hydroxylases binding to substrates. Biochem. Biophys. Res. Commun. 351 (2006) 313-320
45. Hon W.C., Wilson M.I., Harlos K., Claridge T.D.W., Schofield C.J., Pugh C.W., Maxwell P.H., Ratcliffe P.J., Stuart D.I., and Jones Y. Structural basis for the recognition of hydroxyproline in HIF-1α by pVHL. Nature 417 (2002) 975-978
46. Min J.H., Yang H., Ivan M., Gertler F., Kaelin Jr. W.G., and Pavletich N.P. Structure of an HIF-1α-pVHL complex: Hydroxyproline recognition in signaling. Science 296 (2002) 1886-1889
47. Pescador N., Cuevas Y., Naranjo S., Alcaide M., Villar D., Landazuri M.O., and del Peso L. Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene. Biochem. J. 390 (2005) 189-197
48. Nakayama K., Frew I.J., Hagensen M., Skals M., Habelhah H., Bhoumik A., Kadoya T., Erdjument-Bromage H., Tempst P., Frappell P.B., Bowtell D.D., and Ronai Z. Siah2 regulates stability of prolyl-hydroxylases, controls HIF1α abundance, and modulates physiological responses to hypoxia. Cell 117 (2004) 941-952
49. Lipscomb E.A., Sarmiere P.D., Crowder R.J., and Freeman R.S. Expression of the SM-20 gene promotes death in nerve growth factor-dependent sympathetic neurons. J. Neurochem. 73 (1999) 429-432
50. Lipscomb E.A., Sarmiere P.D., and Freeman R.S. SM-20 is a novel mitochondrial protein that causes caspase-dependent cell death in nerve growth factor-dependent neurons. J. Biol. Chem. 276 (2001) 5085-5092
51. Lee S., Nakamura E., Yang H., Wei W., Linggi M.S., Sajan M.P., Farese R.V., Freeman R.S., Carter B.D., Kaelin Jr. W.G., and Schlisio S. Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer. Cancer Cell 8 (2005) 155-167
52. Siddiq A., Ayoub I.A., Chavez J.C., Aminova L., Shah S., LaManna J.C., Patton S.M., Connor J.R., Cherny R.A., Volitakis I., Bush A.I., Langsetmo I., Seeley T., Gunzler V., and Ratan R.R. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J. Biol. Chem. 280 (2005) 41732-41743